SKU : ACR123900 | Price : $4200 | Sep-2017

Description

The Global Active Pharmaceutical Ingredients (API) Market is poised to grow at a CAGR of around 6.6% over the next decade to reach approximately $238.8 billion by 2025. Some of the prominent trends that the market is witnessing include, Growing Geriatric Population, Rapid growth in biopharmaceuticals sector and Technological Advancements in API Manufacturing. 
Based on Therapeutic Area, the market is segregated into oncology, nsaids, neurological disorders, musculoskeletal disorders, cardiovascular disorders, metabolic disorders and other therapeutics uses.
By Drug Type, the market is categorized into OTC prescription drugs, generic prescription drugs and branded prescription drugs. On the basis of Manufacturing Process, the market is segmented into contract manufacturing and captive manufacturing.
Depending on API Type the market is divided into biological API, synthetic chemical API and high potency active pharmaceutical ingredients (HPAPI). The Biological API segment is further categorized into Biotech and Biosimilar. The Synthetic Chemical API segment is further divided into branded/ innovative and generic/non- branded.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2014, 2015 revenue estimations are presented for 2016 and forecasts from 2017 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

This report provides data tables, includes charts and graphs for visual analysis. 

Regional Analysis:
North America
- US
- Canada
- Mexico

Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe

Asia Pacific
- China
- Japan
- India
- Australia
- New Zealand
- Rest of Asia Pacific

Middle East
- Saudi Arabia  
- UAE   
- Rest of Middle East 

Latin America
- Argentina  
- Brazil   
- Rest of Latin America 

Rest of the World
- South Africa
- Others

Report Highlights:
- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2025, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends 
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2025
- Market opportunities and recommendations for new investments

Table of Content

1 Market Outline           
 1.1 Research Methodology       
  1.1.1 Research Approach & Sources     
 1.2 Market Trends         
 1.3 Regulatory Factors        
 1.4 Strategic Benchmarking       
 1.5 Opportunity Analysis       
            
2 Executive Summary          
     
3 Market Overview   
 3.1 Current Trends         
  3.1.1 Growing Geriatric Population
  3.1.2 Rapid growth in biopharmaceuticals sector
  3.1.3 Technological Advancements in Api Manufacturing
  3.1.4 Growth Opportunities/Investment Opportunities
 3.2 Drivers          
 3.3 Constraints         
 3.4 Industry Attractiveness       
  3.4.1 Bargaining power of suppliers     
  3.4.2 Bargaining power of buyers     
  3.4.3 Threat of substitutes     
  3.4.4 Threat of new entrants     
  3.4.5 Competitive rivalry      
     
4 Active Pharmaceutical Ingredients (API) Market, By Therapeutic Area 
 4.1 Oncology   
  4.1.1 Oncology Market Forecast to 2025 (US$ MN)
 4.2 NSAIDs   
  4.2.1 NSAIDs Market Forecast to 2025 (US$ MN)
 4.3 Neurological Disorders 
  4.3.1 Neurological Disorders Market Forecast to 2025 (US$ MN)
 4.4 Musculoskeletal Disorders 
  4.4.1 Musculoskeletal Disorders Market Forecast to 2025 (US$ MN)
 4.5 Cardiovascular Disorders 
  4.5.1 Cardiovascular Disorders Market Forecast to 2025 (US$ MN)
 4.6 Metabolic Disorders 
  4.6.1 Metabolic Disorders Market Forecast to 2025 (US$ MN)
 4.7 Other Therapeutics Uses 
  4.7.1 Other Therapeutics Uses Market Forecast to 2025 (US$ MN)
     
5 Active Pharmaceutical Ingredients (API) Market, By Drug Type 
 5.1 OTC Prescription Drugs 
  5.1.1 OTC Prescription Drugs Market Forecast to 2025 (US$ MN)
 5.2 Generic Prescription Drugs 
  5.2.1 Generic Prescription Drugs Market Forecast to 2025 (US$ MN)
 5.3 Branded Prescription Drugs 
  5.3.1 Branded Prescription Drugs Market Forecast to 2025 (US$ MN)
6 Active Pharmaceutical Ingredients (API) Market, By Manufacturing Process 
 6.1 Contract Manufacturing 
  6.1.1 Contract Manufacturing Market Forecast to 2025 (US$ MN)
 6.2 Captive Manufacturing 
  6.2.1 Captive Manufacturing Market Forecast to 2025 (US$ MN)
     
7 Active Pharmaceutical Ingredients (API) Market, By API Type 
 7.1 Biological API  
  7.1.1 Biological API Market Forecast to 2025 (US$ MN)
   7.1.1.1 Biotech 
    7.1.1.1.1 Biotech Market Forecast to 2025 (US$ MN)
   7.1.1.2 Biosimilar
    7.1.1.2.1 Biosimilar Market Forecast to 2025 (US$ MN)
 7.2 Synthetic Chemical API 
  7.2.1 Synthetic Chemical API Market Forecast to 2025 (US$ MN)
   7.2.1.1 Branded/ Innovative
    7.2.1.1.1 Branded/ Innovative Market Forecast to 2025 (US$ MN)
   7.2.1.2 Generic/Non- Branded
    7.2.1.2.1 Generic/Non- Branded Market Forecast to 2025 (US$ MN)
 7.3 High potency active pharmaceutical ingredients(HPAPI)
  7.3.1 High potency active pharmaceutical ingredients(HPAPI) Market Forecast to 2025 (US$ MN)
     
8 Active Pharmaceutical Ingredients (API) Market, By Geography     
 8.1 North America         
  8.1.1 North America Market Forecast by Countries to 2025 (US$ MN) 
   8.1.1.1 US            
   8.1.1.2 Canada       
   8.1.1.3 Mexico       
 8.2 Europe          
  8.2.1 Europe Market Forecast by Countries to 2025 (US$ MN)  
   8.2.1.1 Germany 
   8.2.1.2 U.K 
   8.2.1.3 Italy 
   8.2.1.4 France 
   8.2.1.5 Spain 
   8.2.1.6 Rest of Europe
 8.3 Asia Pacific         
  8.3.1 Asia Pacific Market Forecast by Countries to 2025 (US$ MN)  
   8.3.1.1 China       
   8.3.1.2 Japan       
   8.3.1.3 India       
   8.3.1.4 Australia      
   8.3.1.5 New Zealand     
   8.3.1.6 Rest of Asia Pacific
 8.4 Middle East         
  8.4.1 Middle East Market Forecast by Countries to 2025 (US$ MN)  
   8.4.1.1 Saudi Arabia     
   8.4.1.2 UAE       
   8.4.1.3 Rest of Middle East      
 8.5 Latin America         
  8.5.1 Latin America Market Forecast by Countries to 2025 (US$ MN)  
   8.5.1.1 Argentina     
   8.5.1.2 Brazil       
   8.5.1.3 Rest of Latin America     
 8.6 Rest of the World (RoW)       
  8.6.1 RoW Market Forecast by Countries to 2025 (US$ MN)   
   8.6.1.1 Africa       
   8.6.1.2 Caribbean     
     
9 Key Player Activities         
 9.1 Acquisitions & Mergers       
 9.2 Agreements, Partnerships, Collaborations and Joint Ventures   
 9.3 Product Launch & Expansions       
 9.4 Other Activities         
     
10 Leading Companies           
 10.1 Teva Pharmaceutical Industries Limited
 10.2 Sun Pharmaceutical Industries Ltd.
 10.3 Merial Inc. (Sanofi) (France)      
 10.4 Merck Animal Health (U.S.)        
 10.5 Elanco Animal Health (U.S.)       
 10.6 Dr. Reddy’s Laboratories Ltd. 
 10.7 Ceva Animal Health, Inc.         
 10.8 Boehringer Ingelheim (Germany)      
 10.9 Bioniche Animal Health (Canada)      
 10.10 Aurobindo Pharma Ltd. 
 10.11 Bayer Healthcare (Germany)      
 10.12 Heska Co. (U.S.)  
 10.13 Novartis International AG 
 10.14 Pfizer, Inc  
 10.15 Zoetis (U.S.)           
 10.16 Virbac        
 10.17 Ranbaxy Laboratories 
     


List of Tables

Table 1 Global Active Pharmaceutical Ingredients (API) Market By Region, Market Forecast (2014-2025) (US$ MN) 
Table 2 Global Active Pharmaceutical Ingredients (API) Market By Therapeutic Area, Market Forecast (2014-2025) (US$ MN)
Table 3 Global Active Pharmaceutical Ingredients (API) Market By Oncology, Market Forecast (2014-2025) (US$ MN)
Table 4 Global Active Pharmaceutical Ingredients (API) Market By NSAIDs, Market Forecast (2014-2025) (US$ MN)
Table 5 Global Active Pharmaceutical Ingredients (API) Market By Neurological Disorders, Market Forecast (2014-2025) (US$ MN)
Table 6 Global Active Pharmaceutical Ingredients (API) Market By Musculoskeletal Disorders, Market Forecast (2014-2025) (US$ MN)
Table 7 Global Active Pharmaceutical Ingredients (API) Market By Cardiovascular Disorders, Market Forecast (2014-2025) (US$ MN)
Table 8 Global Active Pharmaceutical Ingredients (API) Market By Metabolic Disorders, Market Forecast (2014-2025) (US$ MN)
Table 9 Global Active Pharmaceutical Ingredients (API) Market By Other Therapeutics Uses, Market Forecast (2014-2025) (US$ MN)
Table 10 Global Active Pharmaceutical Ingredients (API) Market By Drug Type, Market Forecast (2014-2025) (US$ MN)
Table 11 Global Active Pharmaceutical Ingredients (API) Market By OTC Prescription Drugs, Market Forecast (2014-2025) (US$ MN)
Table 12 Global Active Pharmaceutical Ingredients (API) Market By Generic Prescription Drugs, Market Forecast (2014-2025) (US$ MN)
Table 13 Global Active Pharmaceutical Ingredients (API) Market By Branded Prescription Drugs, Market Forecast (2014-2025) (US$ MN)
Table 14 Global Active Pharmaceutical Ingredients (API) Market By Manufacturing Process , Market Forecast (2014-2025) (US$ MN)
Table 15 Global Active Pharmaceutical Ingredients (API) Market By Contract Manufacturing, Market Forecast (2014-2025) (US$ MN)
Table 16 Global Active Pharmaceutical Ingredients (API) Market By Captive Manufacturing, Market Forecast (2014-2025) (US$ MN)
Table 17 Global Active Pharmaceutical Ingredients (API) Market By API Type, Market Forecast (2014-2025) (US$ MN)
Table 18 Global Active Pharmaceutical Ingredients (API) Market By Biological API, Market Forecast (2014-2025) (US$ MN)
Table 19 Global Active Pharmaceutical Ingredients (API) Market By Biotech, Market Forecast (2014-2025) (US$ MN)
Table 20 Global Active Pharmaceutical Ingredients (API) Market By Biosimilar, Market Forecast (2014-2025) (US$ MN)
Table 21 Global Active Pharmaceutical Ingredients (API) Market By Synthetic Chemical API, Market Forecast (2014-2025) (US$ MN)
Table 22 Global Active Pharmaceutical Ingredients (API) Market By Branded/ Innovative, Market Forecast (2014-2025) (US$ MN)
Table 23 Global Active Pharmaceutical Ingredients (API) Market By Generic/Non- Branded, Market Forecast (2014-2025) (US$ MN)
Table 24 Global Active Pharmaceutical Ingredients (API) Market By High potency active pharmaceutical ingredients(HPAPI), Market Forecast (2014-2025) (US$ MN)
Table 25 North America Active Pharmaceutical Ingredients (API) Market By Country, Market Forecast (2014-2025) (US$ MN) 
Table 26 North America Active Pharmaceutical Ingredients (API) Market By Therapeutic Area, Market Forecast (2014-2025) (US$ MN)
Table 27 North America Active Pharmaceutical Ingredients (API) Market By Oncology, Market Forecast (2014-2025) (US$ MN)
Table 28 North America Active Pharmaceutical Ingredients (API) Market By NSAIDs, Market Forecast (2014-2025) (US$ MN)
Table 29 North America Active Pharmaceutical Ingredients (API) Market By Neurological Disorders, Market Forecast (2014-2025) (US$ MN)
Table 30 North America Active Pharmaceutical Ingredients (API) Market By Musculoskeletal Disorders, Market Forecast (2014-2025) (US$ MN)
Table 31 North America Active Pharmaceutical Ingredients (API) Market By Cardiovascular Disorders, Market Forecast (2014-2025) (US$ MN)
Table 32 North America Active Pharmaceutical Ingredients (API) Market By Metabolic Disorders, Market Forecast (2014-2025) (US$ MN)
Table 33 North America Active Pharmaceutical Ingredients (API) Market By Other Therapeutics Uses, Market Forecast (2014-2025) (US$ MN)
Table 34 North America Active Pharmaceutical Ingredients (API) Market By Drug Type, Market Forecast (2014-2025) (US$ MN)
Table 35 North America Active Pharmaceutical Ingredients (API) Market By OTC Prescription Drugs, Market Forecast (2014-2025) (US$ MN)
Table 36 North America Active Pharmaceutical Ingredients (API) Market By Generic Prescription Drugs, Market Forecast (2014-2025) (US$ MN)
Table 37 North America Active Pharmaceutical Ingredients (API) Market By Branded Prescription Drugs, Market Forecast (2014-2025) (US$ MN)
Table 38 North America Active Pharmaceutical Ingredients (API) Market By Manufacturing Process , Market Forecast (2014-2025) (US$ MN)
Table 39 North America Active Pharmaceutical Ingredients (API) Market By Contract Manufacturing, Market Forecast (2014-2025) (US$ MN)
Table 40 North America Active Pharmaceutical Ingredients (API) Market By Captive Manufacturing, Market Forecast (2014-2025) (US$ MN)
Table 41 North America Active Pharmaceutical Ingredients (API) Market By API Type, Market Forecast (2014-2025) (US$ MN)
Table 42 North America Active Pharmaceutical Ingredients (API) Market By Biological API, Market Forecast (2014-2025) (US$ MN)
Table 43 North America Active Pharmaceutical Ingredients (API) Market By Biotech, Market Forecast (2014-2025) (US$ MN)
Table 44 North America Active Pharmaceutical Ingredients (API) Market By Biosimilar, Market Forecast (2014-2025) (US$ MN)
Table 45 North America Active Pharmaceutical Ingredients (API) Market By Synthetic Chemical API, Market Forecast (2014-2025) (US$ MN)
Table 46 North America Active Pharmaceutical Ingredients (API) Market By Branded/ Innovative, Market Forecast (2014-2025) (US$ MN)
Table 47 North America Active Pharmaceutical Ingredients (API) Market By Generic/Non- Branded, Market Forecast (2014-2025) (US$ MN)
Table 48 North America Active Pharmaceutical Ingredients (API) Market By High potency active pharmaceutical ingredients(HPAPI), Market Forecast (2014-2025) (US$ MN)
Table 49 Europe Active Pharmaceutical Ingredients (API) Market By Country, Market Forecast (2014-2025) (US$ MN) 
Table 50 Europe Active Pharmaceutical Ingredients (API) Market By Therapeutic Area, Market Forecast (2014-2025) (US$ MN)
Table 51 Europe Active Pharmaceutical Ingredients (API) Market By Oncology, Market Forecast (2014-2025) (US$ MN)
Table 52 Europe Active Pharmaceutical Ingredients (API) Market By NSAIDs, Market Forecast (2014-2025) (US$ MN)
Table 53 Europe Active Pharmaceutical Ingredients (API) Market By Neurological Disorders, Market Forecast (2014-2025) (US$ MN)
Table 54 Europe Active Pharmaceutical Ingredients (API) Market By Musculoskeletal Disorders, Market Forecast (2014-2025) (US$ MN)
Table 55 Europe Active Pharmaceutical Ingredients (API) Market By Cardiovascular Disorders, Market Forecast (2014-2025) (US$ MN)
Table 56 Europe Active Pharmaceutical Ingredients (API) Market By Metabolic Disorders, Market Forecast (2014-2025) (US$ MN)
Table 57 Europe Active Pharmaceutical Ingredients (API) Market By Other Therapeutics Uses, Market Forecast (2014-2025) (US$ MN)
Table 58 Europe Active Pharmaceutical Ingredients (API) Market By Drug Type, Market Forecast (2014-2025) (US$ MN)
Table 59 Europe Active Pharmaceutical Ingredients (API) Market By OTC Prescription Drugs, Market Forecast (2014-2025) (US$ MN)
Table 60 Europe Active Pharmaceutical Ingredients (API) Market By Generic Prescription Drugs, Market Forecast (2014-2025) (US$ MN)
Table 61 Europe Active Pharmaceutical Ingredients (API) Market By Branded Prescription Drugs, Market Forecast (2014-2025) (US$ MN)
Table 62 Europe Active Pharmaceutical Ingredients (API) Market By Manufacturing Process , Market Forecast (2014-2025) (US$ MN)
Table 63 Europe Active Pharmaceutical Ingredients (API) Market By Contract Manufacturing, Market Forecast (2014-2025) (US$ MN)
Table 64 Europe Active Pharmaceutical Ingredients (API) Market By Captive Manufacturing, Market Forecast (2014-2025) (US$ MN)
Table 65 Europe Active Pharmaceutical Ingredients (API) Market By API Type, Market Forecast (2014-2025) (US$ MN)
Table 66 Europe Active Pharmaceutical Ingredients (API) Market By Biological API, Market Forecast (2014-2025) (US$ MN)
Table 67 Europe Active Pharmaceutical Ingredients (API) Market By Biotech, Market Forecast (2014-2025) (US$ MN)
Table 68 Europe Active Pharmaceutical Ingredients (API) Market By Biosimilar, Market Forecast (2014-2025) (US$ MN)
Table 69 Europe Active Pharmaceutical Ingredients (API) Market By Synthetic Chemical API, Market Forecast (2014-2025) (US$ MN)
Table 70 Europe Active Pharmaceutical Ingredients (API) Market By Branded/ Innovative, Market Forecast (2014-2025) (US$ MN)
Table 71 Europe Active Pharmaceutical Ingredients (API) Market By Generic/Non- Branded, Market Forecast (2014-2025) (US$ MN)
Table 72 Europe Active Pharmaceutical Ingredients (API) Market By High potency active pharmaceutical ingredients(HPAPI), Market Forecast (2014-2025) (US$ MN)
Table 73 Asia Pacific Active Pharmaceutical Ingredients (API) Market By Country, Market Forecast (2014-2025) (US$ MN) 
Table 74 Asia Pacific Active Pharmaceutical Ingredients (API) Market By Therapeutic Area, Market Forecast (2014-2025) (US$ MN)
Table 75 Asia Pacific Active Pharmaceutical Ingredients (API) Market By Oncology, Market Forecast (2014-2025) (US$ MN)
Table 76 Asia Pacific Active Pharmaceutical Ingredients (API) Market By NSAIDs, Market Forecast (2014-2025) (US$ MN)
Table 77 Asia Pacific Active Pharmaceutical Ingredients (API) Market By Neurological Disorders, Market Forecast (2014-2025) (US$ MN)
Table 78 Asia Pacific Active Pharmaceutical Ingredients (API) Market By Musculoskeletal Disorders, Market Forecast (2014-2025) (US$ MN)
Table 79 Asia Pacific Active Pharmaceutical Ingredients (API) Market By Cardiovascular Disorders, Market Forecast (2014-2025) (US$ MN)
Table 80 Asia Pacific Active Pharmaceutical Ingredients (API) Market By Metabolic Disorders, Market Forecast (2014-2025) (US$ MN)
Table 81 Asia Pacific Active Pharmaceutical Ingredients (API) Market By Other Therapeutics Uses, Market Forecast (2014-2025) (US$ MN)
Table 82 Asia Pacific Active Pharmaceutical Ingredients (API) Market By Drug Type, Market Forecast (2014-2025) (US$ MN)
Table 83 Asia Pacific Active Pharmaceutical Ingredients (API) Market By OTC Prescription Drugs, Market Forecast (2014-2025) (US$ MN)
Table 84 Asia Pacific Active Pharmaceutical Ingredients (API) Market By Generic Prescription Drugs, Market Forecast (2014-2025) (US$ MN)
Table 85 Asia Pacific Active Pharmaceutical Ingredients (API) Market By Branded Prescription Drugs, Market Forecast (2014-2025) (US$ MN)
Table 86 Asia Pacific Active Pharmaceutical Ingredients (API) Market By Manufacturing Process , Market Forecast (2014-2025) (US$ MN)
Table 87 Asia Pacific Active Pharmaceutical Ingredients (API) Market By Contract Manufacturing, Market Forecast (2014-2025) (US$ MN)
Table 88 Asia Pacific Active Pharmaceutical Ingredients (API) Market By Captive Manufacturing, Market Forecast (2014-2025) (US$ MN)
Table 89 Asia Pacific Active Pharmaceutical Ingredients (API) Market By API Type, Market Forecast (2014-2025) (US$ MN)
Table 90 Asia Pacific Active Pharmaceutical Ingredients (API) Market By Biological API, Market Forecast (2014-2025) (US$ MN)
Table 91 Asia Pacific Active Pharmaceutical Ingredients (API) Market By Biotech, Market Forecast (2014-2025) (US$ MN)
Table 92 Asia Pacific Active Pharmaceutical Ingredients (API) Market By Biosimilar, Market Forecast (2014-2025) (US$ MN)
Table 93 Asia Pacific Active Pharmaceutical Ingredients (API) Market By Synthetic Chemical API, Market Forecast (2014-2025) (US$ MN)
Table 94 Asia Pacific Active Pharmaceutical Ingredients (API) Market By Branded/ Innovative, Market Forecast (2014-2025) (US$ MN)
Table 95 Asia Pacific Active Pharmaceutical Ingredients (API) Market By Generic/Non- Branded, Market Forecast (2014-2025) (US$ MN)
Table 96 Asia Pacific Active Pharmaceutical Ingredients (API) Market By High potency active pharmaceutical ingredients(HPAPI), Market Forecast (2014-2025) (US$ MN)
Table 97 Middle East Active Pharmaceutical Ingredients (API) Market By Country, Market Forecast (2014-2025) (US$ MN) 
Table 98 Middle East Active Pharmaceutical Ingredients (API) Market By Therapeutic Area, Market Forecast (2014-2025) (US$ MN)
Table 99 Middle East Active Pharmaceutical Ingredients (API) Market By Oncology, Market Forecast (2014-2025) (US$ MN)
Table 100 Middle East Active Pharmaceutical Ingredients (API) Market By NSAIDs, Market Forecast (2014-2025) (US$ MN)
Table 101 Middle East Active Pharmaceutical Ingredients (API) Market By Neurological Disorders, Market Forecast (2014-2025) (US$ MN)
Table 102 Middle East Active Pharmaceutical Ingredients (API) Market By Musculoskeletal Disorders, Market Forecast (2014-2025) (US$ MN)
Table 103 Middle East Active Pharmaceutical Ingredients (API) Market By Cardiovascular Disorders, Market Forecast (2014-2025) (US$ MN)
Table 104 Middle East Active Pharmaceutical Ingredients (API) Market By Metabolic Disorders, Market Forecast (2014-2025) (US$ MN)
Table 105 Middle East Active Pharmaceutical Ingredients (API) Market By Other Therapeutics Uses, Market Forecast (2014-2025) (US$ MN)
Table 106 Middle East Active Pharmaceutical Ingredients (API) Market By Drug Type, Market Forecast (2014-2025) (US$ MN)
Table 107 Middle East Active Pharmaceutical Ingredients (API) Market By OTC Prescription Drugs, Market Forecast (2014-2025) (US$ MN)
Table 108 Middle East Active Pharmaceutical Ingredients (API) Market By Generic Prescription Drugs, Market Forecast (2014-2025) (US$ MN)
Table 109 Middle East Active Pharmaceutical Ingredients (API) Market By Branded Prescription Drugs, Market Forecast (2014-2025) (US$ MN)
Table 110 Middle East Active Pharmaceutical Ingredients (API) Market By Manufacturing Process , Market Forecast (2014-2025) (US$ MN)
Table 111 Middle East Active Pharmaceutical Ingredients (API) Market By Contract Manufacturing, Market Forecast (2014-2025) (US$ MN)
Table 112 Middle East Active Pharmaceutical Ingredients (API) Market By Captive Manufacturing, Market Forecast (2014-2025) (US$ MN)
Table 113 Middle East Active Pharmaceutical Ingredients (API) Market By API Type, Market Forecast (2014-2025) (US$ MN)
Table 114 Middle East Active Pharmaceutical Ingredients (API) Market By Biological API, Market Forecast (2014-2025) (US$ MN)
Table 115 Middle East Active Pharmaceutical Ingredients (API) Market By Biotech, Market Forecast (2014-2025) (US$ MN)
Table 116 Middle East Active Pharmaceutical Ingredients (API) Market By Biosimilar, Market Forecast (2014-2025) (US$ MN)
Table 117 Middle East Active Pharmaceutical Ingredients (API) Market By Synthetic Chemical API, Market Forecast (2014-2025) (US$ MN)
Table 118 Middle East Active Pharmaceutical Ingredients (API) Market By Branded/ Innovative, Market Forecast (2014-2025) (US$ MN)
Table 119 Middle East Active Pharmaceutical Ingredients (API) Market By Generic/Non- Branded, Market Forecast (2014-2025) (US$ MN)
Table 120 Middle East Active Pharmaceutical Ingredients (API) Market By High potency active pharmaceutical ingredients(HPAPI), Market Forecast (2014-2025) (US$ MN)
Table 121 Latin America Active Pharmaceutical Ingredients (API) Market By Country, Market Forecast (2014-2025) (US$ MN) 
Table 122 Latin America Active Pharmaceutical Ingredients (API) Market By Therapeutic Area, Market Forecast (2014-2025) (US$ MN)
Table 123 Latin America Active Pharmaceutical Ingredients (API) Market By Oncology, Market Forecast (2014-2025) (US$ MN)
Table 124 Latin America Active Pharmaceutical Ingredients (API) Market By NSAIDs, Market Forecast (2014-2025) (US$ MN)
Table 125 Latin America Active Pharmaceutical Ingredients (API) Market By Neurological Disorders, Market Forecast (2014-2025) (US$ MN)
Table 126 Latin America Active Pharmaceutical Ingredients (API) Market By Musculoskeletal Disorders, Market Forecast (2014-2025) (US$ MN)
Table 127 Latin America Active Pharmaceutical Ingredients (API) Market By Cardiovascular Disorders, Market Forecast (2014-2025) (US$ MN)
Table 128 Latin America Active Pharmaceutical Ingredients (API) Market By Metabolic Disorders, Market Forecast (2014-2025) (US$ MN)
Table 129 Latin America Active Pharmaceutical Ingredients (API) Market By Other Therapeutics Uses, Market Forecast (2014-2025) (US$ MN)
Table 130 Latin America Active Pharmaceutical Ingredients (API) Market By Drug Type, Market Forecast (2014-2025) (US$ MN)
Table 131 Latin America Active Pharmaceutical Ingredients (API) Market By OTC Prescription Drugs, Market Forecast (2014-2025) (US$ MN)
Table 132 Latin America Active Pharmaceutical Ingredients (API) Market By Generic Prescription Drugs, Market Forecast (2014-2025) (US$ MN)
Table 133 Latin America Active Pharmaceutical Ingredients (API) Market By Branded Prescription Drugs, Market Forecast (2014-2025) (US$ MN)
Table 134 Latin America Active Pharmaceutical Ingredients (API) Market By Manufacturing Process , Market Forecast (2014-2025) (US$ MN)
Table 135 Latin America Active Pharmaceutical Ingredients (API) Market By Contract Manufacturing, Market Forecast (2014-2025) (US$ MN)
Table 136 Latin America Active Pharmaceutical Ingredients (API) Market By Captive Manufacturing, Market Forecast (2014-2025) (US$ MN)
Table 137 Latin America Active Pharmaceutical Ingredients (API) Market By API Type, Market Forecast (2014-2025) (US$ MN)
Table 138 Latin America Active Pharmaceutical Ingredients (API) Market By Biological API, Market Forecast (2014-2025) (US$ MN)
Table 139 Latin America Active Pharmaceutical Ingredients (API) Market By Biotech, Market Forecast (2014-2025) (US$ MN)
Table 140 Latin America Active Pharmaceutical Ingredients (API) Market By Biosimilar, Market Forecast (2014-2025) (US$ MN)
Table 141 Latin America Active Pharmaceutical Ingredients (API) Market By Synthetic Chemical API, Market Forecast (2014-2025) (US$ MN)
Table 142 Latin America Active Pharmaceutical Ingredients (API) Market By Branded/ Innovative, Market Forecast (2014-2025) (US$ MN)
Table 143 Latin America Active Pharmaceutical Ingredients (API) Market By Generic/Non- Branded, Market Forecast (2014-2025) (US$ MN)
Table 144 Latin America Active Pharmaceutical Ingredients (API) Market By High potency active pharmaceutical ingredients(HPAPI), Market Forecast (2014-2025) (US$ MN)
Table 145 RoW Active Pharmaceutical Ingredients (API) Market By Country, Market Forecast (2014-2025) (US$ MN) 
Table 146 RoW Active Pharmaceutical Ingredients (API) Market By Therapeutic Area, Market Forecast (2014-2025) (US$ MN)
Table 147 RoW Active Pharmaceutical Ingredients (API) Market By Oncology, Market Forecast (2014-2025) (US$ MN)
Table 148 RoW Active Pharmaceutical Ingredients (API) Market By NSAIDs, Market Forecast (2014-2025) (US$ MN)
Table 149 RoW Active Pharmaceutical Ingredients (API) Market By Neurological Disorders, Market Forecast (2014-2025) (US$ MN)
Table 150 RoW Active Pharmaceutical Ingredients (API) Market By Musculoskeletal Disorders, Market Forecast (2014-2025) (US$ MN)
Table 151 RoW Active Pharmaceutical Ingredients (API) Market By Cardiovascular Disorders, Market Forecast (2014-2025) (US$ MN)
Table 152 RoW Active Pharmaceutical Ingredients (API) Market By Metabolic Disorders, Market Forecast (2014-2025) (US$ MN)
Table 153 RoW Active Pharmaceutical Ingredients (API) Market By Other Therapeutics Uses, Market Forecast (2014-2025) (US$ MN)
Table 154 RoW Active Pharmaceutical Ingredients (API) Market By Drug Type, Market Forecast (2014-2025) (US$ MN)
Table 155 RoW Active Pharmaceutical Ingredients (API) Market By OTC Prescription Drugs, Market Forecast (2014-2025) (US$ MN)
Table 156 RoW Active Pharmaceutical Ingredients (API) Market By Generic Prescription Drugs, Market Forecast (2014-2025) (US$ MN)
Table 157 RoW Active Pharmaceutical Ingredients (API) Market By Branded Prescription Drugs, Market Forecast (2014-2025) (US$ MN)
Table 158 RoW Active Pharmaceutical Ingredients (API) Market By Manufacturing Process , Market Forecast (2014-2025) (US$ MN)
Table 159 RoW Active Pharmaceutical Ingredients (API) Market By Contract Manufacturing, Market Forecast (2014-2025) (US$ MN)
Table 160 RoW Active Pharmaceutical Ingredients (API) Market By Captive Manufacturing, Market Forecast (2014-2025) (US$ MN)
Table 161 RoW Active Pharmaceutical Ingredients (API) Market By API Type, Market Forecast (2014-2025) (US$ MN)
Table 162 RoW Active Pharmaceutical Ingredients (API) Market By Biological API, Market Forecast (2014-2025) (US$ MN)
Table 163 RoW Active Pharmaceutical Ingredients (API) Market By Biotech, Market Forecast (2014-2025) (US$ MN)
Table 164 RoW Active Pharmaceutical Ingredients (API) Market By Biosimilar, Market Forecast (2014-2025) (US$ MN)
Table 165 RoW Active Pharmaceutical Ingredients (API) Market By Synthetic Chemical API, Market Forecast (2014-2025) (US$ MN)
Table 166 RoW Active Pharmaceutical Ingredients (API) Market By Branded/ Innovative, Market Forecast (2014-2025) (US$ MN)
Table 167 RoW Active Pharmaceutical Ingredients (API) Market By Generic/Non- Branded, Market Forecast (2014-2025) (US$ MN)
Table 168 RoW Active Pharmaceutical Ingredients (API) Market By High potency active pharmaceutical ingredients(HPAPI), Market Forecast (2014-2025) (US$ MN)

Request Sample

Choose License

Speak to Analyst

Request for Discount